글로벌 면역 탁도 측정 시약 시장 – 2029년까지의 산업 동향 및 예측

 면역 탁도 측정 시약 시장 분석 및 규모

면역탁도법(IT)은 광범위한 임상 화학 분야에서 중요한 진단 기술입니다. 전통적인 임상 화학 방법과 항원-항체 반응을 사용하여 검출할 수 없는 혈청 단백질을 식별하는 데 사용됩니다. 면역탁도법은 항원과 항체의 특이적이고 민감한 상호 작용에 의존합니다. 각 항체는 다른 항원(열쇠와 자물쇠)에 결합합니다.

Data Bridge Market Research는 2022년부터 2029년까지의 예측 기간 동안 6.50%의 건강한 CAGR이 예상되는 면역 탁도계 시약 시장을 분석합니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

면역 탁도 측정 시약 시장 범위 및 세분화      

Market Definition

Immunoturbidimetry is an appropriate technique for determining urinary proteins in clinical laboratories. We created immunoturbidimetric assays for measuring urinary albumin and transferrin that are compatible with the Cobas-BIO centrifugal analyzer.  The ability of immune-complex precipitates to interact with incident light is quantified using turbidimetry (immunoturbidimetry) and nephelometry (immunonephelometry). The detector is oriented at a straight-on 180-degree angle relative to the incident light source for turbidimetric measurements. Immunoturbidimetry Reagents are available for the estimation of RF, ASO, CRP and Direct HbA1c.

Global Immunoturbidimetry Reagents Market Dynamics

Drivers

• Growing need of IVD testing

The growing demand for IVD testing is driven by rising rates of chronic and infectious diseases, as well as an ageing population prone to immunological disorders. Furthermore, increased use of personalised medicines and increased awareness of rare diseases are propelling the market. Another rise in testing specific proteins for infectious diseases, cardiac diseases, diabetes, autoimmune disorders, inflammatory markers, and other conditions has been observed. These are the certain factors which propel the growth of market.

• Rising cardiovascular diseases

India is experiencing a rapid demographic transition. By 2050, the percentage population of the elderly (aged 60 and up) is expected to increase by about 20%. According to the LASI (The Longitudinal Ageing Study in India) report, the burden of noncommunicable illness is increasing. It is estimated that 45 million people have cardiovascular disease and high blood pressure, 20 million have diabetes, and 24% have difficulty performing daily activities and this factor is propelling the growth of the market.

Opportunities

• Rising number of patients

The rising number of patients suffering from breast autoimmune disorders, cardiac diseases, diabetes, infectious diseases, and inflammatory markers is expected to have a significant impact on the immunoturbidimetry reagents market from 2022 to 2029. On the other hand, the growing patient population will create additional opportunities for the immunoturbidimetry reagents market during the forecast period.

Restraints/Challenges

• High consumables cost

High consumables costs and need of trained and experienced personal will hamper the growth of the immunoturbidimetry reagents will obstruct the market's growth rate.

High consumable costs necessitate highly trained person. Immunoturbidimetric tests are performed on routine biochemistry analyzers, which are versatile, fast, and cost-effective, with longer reagent stability. The primary benefit of nephelometry was its sensitivity; however, latex-enhanced immunoturbidimetry has closed this gap.

This immunoturbidimetry reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the immunoturbidimetry reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Immunoturbidimetry Reagents Market Scope

The immunoturbidimetry reagents market is segmented on the basis of indication, application, technology and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

• Kidney Function Test
• Diabetes
• High Blood Pressure
• IVD Test

Application

• Proteomics
• Drug discovery and Development
• Genomics

 Technology

• Western Blot
• Immunofluorescence
• Immunohistochemistry
• Flow Cytometry
• Enzyme-linked Immunosorbent Assay
• Multiplex Immunosorbent Assay
• Immunoprecipitation
• Others

 End User

• Hospitals
• Home care settings
• Clinical Laboratories
• Others

Immunoturbidimetry Reagents Market Regional Analysis/Insights

The immunoturbidimetry reagents market is analysed and market size insights and trends are provided by country, indication, application, technology and end user as referenced above.

The countries covered in the immunoturbidimetry reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the immunoturbidimetry reagents market due to the high prevalence of local players in the market, rise in the adoption of targeted immunotherapy.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the rising awareness amongst people regarding diabetes and high blood pressure-related conditions.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 면역 탁도 측정 시약 시장 점유율 분석

면역탁도계 시약 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 면역탁도계 시약 시장과 관련된 회사의 초점에만 관련이 있습니다.

면역탁도측정 시약 시장에서 활동하는 주요 업체는 다음과 같습니다.

• 지멘스 헬스케어 프라이빗 리미티드(독일)
• Randox Laboratories Ltd. (영국)
• BBI 솔루션(영국)
• 애벗(미국)
• FUJIFILM India Private Limited (미국)
• 에르바 만하임(독일)
• 바이오컴페어(미국)

SKU-55717